CEO says pharma executives discussed Trump's call to launch DTC initiatives under his Most Favored Nation policy to lower U.S ...

Pfizer said its full-year profit should benefit from cost cuts across its research and manufacturing operations after posting ...

As investors and industry watchers juggle the twin possibilities of pharmaceutical import tariffs and potential drug pricing ...

Pfizer ( PFE) CEO Albert Bourla said Tuesday he has a "special relationship" with President Trump, cemented during the ...

Pfizer CEO says drugmakers ‘are all ready to roll up their sleeves and execute’ as president demands more direct-to-consumer ...

George Tidmarsh takes over temporarily at CBER following Vinay Prasad’s abrupt departure; Replimmune trial leaders protest ...

Last week, President Trump sent letters to 17 major pharmaceutical companies advising them to work with his administration to ...

When President Donald Trump hits "post" on Truth Social, Wall Street braces for impact. What Happened: Various stock prices — ...

Latest move to cut funding for vaccines is not down to US health secretary. It is part of Trump’s wider war on science.

The president who ran on his business acumen isn’t holding back in telling corporate bosses how to run their companies—or ...

SERB Pharmaceuticals plans to buy Y-mAbs Pharmaceuticals in a $412 million all-cash deal. CorMedix bought Melinta ...

Chief Executive Albert Bourla told analysts he is hopeful about finding a solution in response to President Trump’s demands.